Eli Lilly Sues Clinics Over Alleged Sales of Unapproved Versions of Diabetes Drug

A sign outside an Eli Lilly pharmaceutical manufacturing plant in Branchburg, N.J., on March 5, 2021. Mike Segar/Reuters

Pharmaceutical giant Eli Lilly has filed a lawsuit against multiple medical spas, wellness centers, and compounding pharmacies across the United States in an effort to stop them from allegedly selling products claiming to contain tirzepatide, which is the active ingredient in the company’s diabetes drug Mounjaro.

Announcing the legal challenges in a Sept. 19 press release Eli Lilly said the suits were filed against the various spas and centers to “protect patients.”